CAMBRIDGE, MA: At a time when an increasing number of biotechnology products are coming to market, one of the industry's most prominent trade organizations, the Massachusetts Biotechnology Council (MBC), has created its first-ever director of communications post.
Vicki Greene, former vice president in Weber Shandwick's Boston life-sciences practice, has accepted the job.
The new role was created when the MBC assembled a research report that revealed a great deal of confusion among constituencies about what biotechnology companies actually do, as well as what value they add to the economy of Massachusetts.
"People hear biotechnology and they think lab coats," said Greene. "Of course, work is being done in laboratories, but we want people to understand it in terms of how biotech companies are improving quality of life."
Approximately 280 of the MBC's 400 members are individual biotech companies, which include Genzyme, Biogen, and Novartis' Institute for Biomedical Research.
"A lot of our member companies are getting much bigger." explained Greene. "So it is our job to communicate with consumers, state officials, and business owners about the benefits of having those companies stay in Massachusetts to manufacture their products."